Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

UTI Mutual Fund

UTI Innovation Fund - Regular Plan - Growth Option

★★★★★ TopFund est.

TopFund Score (fallback rating)

  • Calculated by: TopFund — used only when no third-party rating exists for this fund
  • Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis

Full rating methodology →

TopFund Score: 36/100 · Weak

How this score is calculated

  • Star rating (35%)1/5
  • 3Y CAGR (30%)4.44%
  • Expense ratio (20%)1.21%
  • AUM (15%)₹768 Cr

Not investment advice — an analytical read of public fund data. Methodology →

UTI Mutual Fund · Equity · Thematic

₹11.64

+0.49 (+4.37%)

AUM: ₹767 Cr

NAV updated 14 days ago

Plan

Regular

Option

Growth

Risk

Very High

Expense Ratio

1.21%

Exit Load

Exit load of 1%, if redeemed within 12 months.

Fund Manager

Deepesh Agarwal

Inception

Oct 2023

Benchmark

NIFTY 500 Total Return Index

Sharpe Ratio

-0.65

Std Dev (1Y)

19.74%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+2.95%

3m

-2.96%

6m

+7.65%

1y

-6.88%

3y

+4.44%

5y

—

10y

—

since inception

+3.58%

TopFund's Take on UTI Innovation Fund - Regular Plan - Growth Option

UTI Innovation Fund - Regular Plan - Growth Option lags behind most of its peers in the Thematic category, currently carrying a 1-star rating. Returns have been soft relative to what the category has offered — worth checking if this is a temporary phase or a longer pattern. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 36/100.

Cost: At 1.21%, the expense ratio runs 17% above the Thematic category average of 1.03%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.65 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 19.74% is fairly typical for Thematic funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Asset Allocation

Equity 96.15%
Net Current Assets 3.83%
CBLO 0.02%

Frequently Asked Questions about UTI Innovation Fund - Regular Plan - Growth Option

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.